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ARTICLE
DDX5 plays essential transcriptional and post-
transcriptional roles in the maintenance and
function of spermatogonia
Julien M.D. Legrand 1,2, Ai-Leen Chan1,2, Hue M. La 1,2, Fernando J. Rossello1,3, Minna-Liisa Änkö1,4,
Frances V. Fuller-Pace5 & Robin M. Hobbs 1,2
Mammalian spermatogenesis is sustained by mitotic germ cells with self-renewal potential
known as undifferentiated spermatogonia. Maintenance of undifferentiated spermatogonia
and spermatogenesis is dependent on tightly co-ordinated transcriptional and post-
transcriptional mechanisms. The RNA helicase DDX5 is expressed by spermatogonia but
roles in spermatogenesis are unexplored. Using an inducible knockout mouse model, we
characterise an essential role for DDX5 in spermatogonial maintenance and show that Ddx5
is indispensable for male fertility. We demonstrate that DDX5 regulates appropriate splicing
of key genes necessary for spermatogenesis. Moreover, DDX5 regulates expression of cell
cycle genes in undifferentiated spermatogonia post-transcriptionally and is required for cell
proliferation and survival. DDX5 can also act as a transcriptional co-activator and we
demonstrate that DDX5 interacts with PLZF, a transcription factor required for germline
maintenance, to co-regulate select target genes. Combined, our data reveal a critical multi-
functional role for DDX5 in regulating gene expression programmes and activity of undif-
ferentiated spermatogonia.
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The maintenance of adult tissue integrity and function isoften dependent upon a population of resident stem cellsthat self-renews and generates differentiating cells. The
balance between stem cell self-renewal and differentiation can be
regulated through extrinsic stimuli, including growth factors
produced in a supportive niche, as well as cell intrinsic factors
such as transcription factors and post-transcriptional gene reg-
ulatory mechanisms. The mammalian testis is an example of such
a tissue where tightly co-ordinated transcriptional and post-
transcriptional mechanisms harmonise to ensure lifelong main-
tenance of fertility through the continual production of mature
spermatozoa1.
In mammals, spermatozoa are produced through the complex
process of spermatogenesis that is maintained by a population of
cells with self-renewal potential referred to as undifferentiated
spermatogonia. During spermatogenesis, undifferentiated sper-
matogonia undergo mitotic divisions followed by induction of
differentiation that ultimately results in production of meiotic
spermatocytes. After two meiotic reduction divisions, round
spermatids are formed that undergo signiﬁcant morphological
changes during a process known as spermiogenesis to ultimately
produce haploid spermatozoa1. The entire process of spermato-
genesis occurs within seminiferous tubules of the testis and is
supported by Sertoli cells, essential somatic components that
produce GDNF, a growth factor critical for spermatogonial
maintenance2. In homoeostatic testis, only a proportion of
undifferentiated spermatogonia function as stem cells, while the
remainder act as differentiation-committed progenitors. How-
ever, progenitor populations can revert to a stem cell state fol-
lowing germ cell depletion and induction of a regenerative
response3,4. Self-renewing cells within the steady-state undiffer-
entiated spermatogonial pool are marked by expression of Gfra1,
Nanos2, and Id4 while committed progenitors express Ngn3,
Sox3, and Rarg3–8. Spermatogonial differentiation is marked by
induction of the cell surface receptor c-KIT and a series of
coordinated mitotic divisions prior to meiosis2,9. Progression of
germ cells through the differentiation pathway is associated with
incomplete cytokinesis following cell division, a conserved feature
of germline systems between species7. Within the undifferentiated
compartment, the most primitive cells generally exist as single
cells termed Asingle (As) that can divide to produce As daughters
for self-renewal or pairs (Apaired or Apr) and subsequently longer
chains of cells that reach 16 cells or more (Aaligned or Aal) and are
typically differentiation-primed7 (Fig. 1a). Importantly, in the
presence of GDNF and bFGF growth factors, undifferentiated
spermatogonia can be cultured long-term in vitro while main-
taining stem cell potential10.
In addition to extrinsic stimuli, the maintenance and function
of undifferentiated spermatogonia are dependent on a complex
network of cell intrinsic factors that co-ordinately regulate tran-
scription. Amongst these, transcription factors such as PLZF and
SALL4 are important for spermatogonial self-renewal and dif-
ferentiation, respectively11–14. PLZF maintains self-renewal
capacity by enhancing sensitivity of undifferentiated spermato-
gonia to GDNF through indirect inhibition of
mTORC1 signalling14–16. mTORC1 is a key regulator of mRNA
translation, as well as cellular metabolism and aberrant activation
of this pathway drives differentiation commitment of spermato-
gonia in vivo14,17. SALL4 was demonstrated to modulate PLZF
function in undifferentiated spermatogonia and is required for
their differentiation13. More recently, we have demonstrated that
SALL4 is also required in a PLZF-independent manner for long-
term maintenance of undifferentiated spermatogonia activity and
regeneration following germline depletion12. Other important
transcriptional regulators of spermatogonial self-renewal and
differentiation have been identiﬁed such as ETV518 and
SOHLH1/28, respectively; however, despite the uncovering of
numerous factors, much remains to be understood regarding
their interplay in this intricate process.
Besides regulation at the transcriptional level, periods of
transcriptional quiescence occurring in spermatogenesis during
meiotic homologous recombination and spermiogenesis necessi-
tates post-transcriptional regulation of gene expression1.
Numerous regulators of alternative pre-mRNA splicing, mRNA
export and stability, as well as translational control have been
shown to be essential for timely gene expression during sper-
matogenesis1. The RNA-binding protein NANOS2 maintains the
undifferentiated state of spermatogonia by recruiting
differentiation-associated mRNAs to ribonucleoprotein com-
plexes and inhibiting their translation19. NANOS2 also directly
inhibits mTORC1 through sequestration of the mTOR kinase,
thus robustly suppressing translation of mRNAs required for
differentiation19. More recently, BCAS2 has been shown to be an
essential regulator of alternative pre-mRNA splicing in sperma-
togonia20. Loss of BCAS2 in male mice results in infertility as a
consequence of aberrant splicing of genes necessary for meiotic
initiation20. While spermatogonial fate is regulated by both
transcriptional and post-transcriptional mechanisms, involve-
ment of speciﬁc RNA processing factors in the maintenance and
function of undifferentiated spermatogonia is poorly appreciated.
DEAD box helicase 5 (DDX5) is an ATP-dependent RNA
helicase originally described as important for the unwinding of
RNA secondary structure, but now known to be involved in
multiple aspects of RNA processing including splicing, mRNA
export, transcript stability, rRNA biogenesis, and microRNA
processing21–25. DDX5 belongs to the DEAD box protein family,
which is characterised by a conserved Asp-Glu-Ala-Asp (DEAD)
motif within a helicase core22. Although the helicase core is lar-
gely conserved amongst DEAD box family members, highly
variable N-terminal and C-terminal regions confer additional
roles to these proteins including the ability to bind DNA and act
as transcriptional co-factors in conjunction with partner tran-
scription factors22,26. In particular, DDX5 acts as a transcriptional
co-factor for MYOD and RUNX2, key regulators of myogenesis
and skeletal development, respectively27,28. DDX5 has also been
implicated in progression of breast and prostate cancer due to its
ability to act as a co-activator of oestrogen and androgen receptor
signalling22,29.
Previous studies have suggested a role for DDX5 in the male
germline; DDX5 was found to be speciﬁcally expressed in human
spermatogonia through validation of single cell RNA-sequencing
(RNA-seq), and the RNA-binding protein RBM5 was found to
interact with DDX5 in mouse round spermatids and be required
for spermatogenesis30,31. DDX5 has also been suggested to be a
negative regulator of WNT signalling in the GC-1spg germ cell
line32. Despite its expression within the male germline, a precise
role for DDX5 has not been elucidated and its involvement in
maintenance of spermatogenesis is unknown. In this study, we
identiﬁed DDX5 as an interacting partner of PLZF in sperma-
togonia and found that DDX5 is indispensable for maintenance
of spermatogenesis in mice. We demonstrate that DDX5 has a
multifaceted role within undifferentiated spermatogonia that
includes both transcriptional and post-transcriptional functions.
We show that DDX5 is important for multiple RNA processing
steps including pre-mRNA splicing of key genes required for
spermatogenesis, as well as the regulation of mRNA nuclear
export and transcript stability of cell cycle-related genes. In
addition, we provide evidence that DDX5 is involved in tran-
scriptional regulation together with PLZF. Our data uncovers an
essential role for DDX5 within undifferentiated and differentiat-
ing spermatogonia, and characterises DDX5 as a critical regulator
of male fertility.
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Fig. 1 DDX5 associates with PLZF and is expressed throughout the male germline. a Schematic depicting the mouse seminiferous tubule and populations of
undifferentiated spermatogonia (As, Apr and Aal), as well as differentiating spermatogonia (A1–A4, In, B) residing on the basement membrane. Commonly
used markers expressed within each population are shown below. DDX5 is ubiquitously expressed within spermatogonial populations. Other
spermatogenic cells are depicted in a cross-section schematic (large black square). Spg: spermatogonia, PSp: primary spermatocyte, SSp: secondary
spermatocyte, RSt: round spermatid, ESt: elongated spermatid, Sert.: Sertoli cells. b Reciprocal co-immunoprecipitation followed by western blot showing
pull down of DDX5 and PLZF using antibodies against each versus IgG control pull down. c Adult mouse seminiferous tubule cross-section showing nuclear
expression of DDX5 in all VASA-positive germ cells. dMouse seminiferous tubule whole mount immunoﬂuorescence showing nuclear expression of DDX5
in SOX9-positive Sertoli cells. e Adult mouse seminiferous tubule whole mount immunoﬂuorescence showing expression of DDX5 in stem/self-renewing
(GFRα1-positive), progenitor (SOX3-positive) and differentiating (c-KIT-positive) spermatogonia populations. GILZ used as a broad marker of
spermatogonia. Representative cells are demarcated with dashed lines and white arrowheads and shown in zoom insets. Seminiferous tubule border
marked with dotted lines. All scale bars= 50 μm
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Results
DDX5 is expressed in the testis and associates with PLZF.
Previous studies have demonstrated that PLZF is important for
self-renewal of undifferentiated spermatogonia in mice14. To
understand further the role of PLZF within the male germline, we
performed PLZF immunoprecipitation (IP) on lysates from cul-
tured wildtype murine undifferentiated spermatogonia followed
by mass spectrometry (MS) analysis to identify interacting pro-
teins12. Including the known PLZF-interacting protein SALL413,
we identiﬁed putative PLZF binding partners (Supplementary
Data 1) with DDX5 amongst the top hits deﬁned by presence in
each of three independent samples. We conﬁrmed this interaction
by reciprocal co-IP and western blot where we observed bands at
expected molecular weights when probing for PLZF (75 kDa) and
DDX5 (68 kDa) (Fig. 1b). Next, we assessed in vivo expression of
DDX5 in mouse seminiferous tubules by immunoﬂuorescence
(IF) of testis sections and found nuclear DDX5 expression within
all spermatogenic cells (spermatogonia, spermatocytes, sperma-
tids) marked by the germ cell marker VASA33,34 and dis-
tinguished according to their location within the seminiferous
tubule35 (Fig. 1a, c). In addition, we examined expression of
DDX5 in non-human primate (marmoset) and human testis
sections and observed a comparable expression pattern in sper-
matogenic cells to that of mouse, including within PLZF-positive
cells (Supplementary Fig. 1a, b).
As spermatogonia reside adjacent to the seminiferous tubule
basement membrane, whole mount IF can be used to distinguish
subsets of spermatogonia through the presence of speciﬁc
markers plus according to their morphology and topology7.
Using this method, we examined expression of DDX5 within self-
renewing, committed progenitor, and differentiating spermato-
gonia. First, we found DDX5 expressed within supporting Sertoli
cells as shown by co-localisation with the Sertoli cell marker,
SOX936 (Fig. 1d). Next, we observed DDX5 expression localised
to the nuclei of GFRα1-positive (self-renewing, As and Apr)3,
SOX3-positive (committed progenitor, Aal)8, and c-KIT-positive
(differentiating)1,9 spermatogonia, with GILZ used as a broad
spermatogonial marker37 (Fig. 1a, e). We concluded that DDX5 is
expressed throughout the male germline and in supporting
somatic cells.
DDX5 is essential for the maintenance of spermatogenesis. To
deﬁne the functional role of DDX5 in the adult male germline, we
sought to ablate Ddx5 using a conditional knockout model.
Previously, we have used transgenic mice containing a tamoxifen-
inducible Cre recombinase under control of the ubiquitin c pro-
moter (UBC-CreERT2)38 to drive efﬁcient Cre-LoxP-mediated
gene recombination in spermatogonia, while meiotic and testis
somatic cells remain mostly unaffected12. We crossed UBC-
CreERT2 mice with previously described Ddx5ﬂox/ﬂox mice39 to
generate a tamoxifen-inducible Ddx5 knockout line (Ddx5ﬂox/ﬂox;
UBC-CreERT2). We treated 8-week-old to 12-week-old male
Ddx5ﬂox/ﬂox; UBC-CreERT2 mice (Ddx5TAM-KO) and Ddx5ﬂox/ﬂox
control mice with tamoxifen (TAM) and collected testis samples
5, 7, 14, and 30 days (D) post-treatment. Analysis of testis sec-
tions by IF revealed a notable loss of PLZF-positive spermato-
gonia by D7 following TAM-induced Ddx5 ablation (Fig. 2a). To
verify loss of all PLZF-positive spermatogonial subsets, we stained
testis sections for markers of self-renewing (GFRα1), progenitor
(SOX3) and differentiating (c-KIT) cells (Supplementary Fig. 2).
We did not observe any Ddx5-ablated cells remaining in these
spermatogonial populations by IF at D7 post-TAM treatment,
besides few c-KIT-positive cells adjacent to the basement mem-
brane of seminiferous tubules (Supplementary Fig. 2c). In addi-
tion, we quantiﬁed Ddx5 ablation and total cell numbers for
Sertoli cells, spermatocytes, and round spermatids by IF at D7
(Supplementary Fig. 3). We found no signiﬁcant difference in the
number of Sertoli cells, spermatocytes or round spermatids
between control and TAM-treated Ddx5TAM-KO testis cross-
sections. Moreover, we found no signiﬁcant differences in the
proportion of those cells positive for DDX5, suggesting the model
used in this study does not result in signiﬁcant Ddx5 ablation
within testis cells other than spermatogonia (Supplementary
Fig. 3). Interestingly, in both control and TAM-treated Ddx5TAM-
KO testis we noted that DDX5 was downregulated in a subset of
SYCP3-positive meiotic cells proximal to the basement mem-
brane, suggesting dynamic regulation of DDX5 during meiosis
(Supplementary Fig. 3b). Next, we analysed populations of
spermatogonia isolated from whole testis samples up to D14 post-
TAM by intracellular staining and ﬂow cytometry according to
expression of PLZF and c-KIT12,13,17. We observed signiﬁcant
reduction of undifferentiated (PLZF+ c-KIT−), early differ-
entiating (PLZF+ c-KIT+) and late differentiating spermatogonia
(PLZFlow c-KIT+) in Ddx5TAM-KO testes by D5 post-TAM
compared with control, with these signiﬁcant reductions per-
sisting through to D14 (Supplementary Fig. 4a, b).
By D30 post-Ddx5 ablation, analysis of testis cross-sections by
IF revealed seminiferous tubules completely devoid of germ cells
as indicated by the absence of VASA-positive cells and a Sertoli
cell-only phenotype (Fig. 2a). Whole mount IF of seminiferous
tubules at D30 post-Ddx5 ablation conﬁrmed signiﬁcant loss of
PLZF-positive spermatogonia, with only Ddx5-retaining Sertoli
cells visible in most TAM-treated Ddx5TAM-KO tubules (Fig. 2b).
Only tubules where rare Ddx5-retaining PLZF-positive sperma-
togonia were present showed indications of germ cell repopula-
tion (Supplementary Fig. 4c). At D30, TAM-treated Ddx5TAM-KO
testes weighed signiﬁcantly less than control testes as anticipated
(0.12 ± 0.01% of total body mass versus 0.30 ± 0.01%, mean ±
SEM, n= 18 control, n= 20 TAM, P < 0.0001, two-tailed
unpaired t-test) (Fig. 2c). Quantiﬁcation of PLZF-positive cells
per tubule cross-section demonstrated signiﬁcant reduction in
numbers of spermatogonia at D5, D7, D14, and D30 in TAM-
treated Ddx5TAM-KO testes compared with controls (Fig. 2d).
Besides this testis phenotype, no other overt phenotype was
observed in Ddx5TAM-KO mice and no signiﬁcant difference in
body mass was discerned at any time point (Fig. 2e). This is of
interest given that UBC-CreERT2 is broadly expressed in adults38,
and TAM treatment of Ddx5TAM-KO mice would ablate Ddx5 in
multiple tissues besides the testis. Our data indicate that DDX5
plays critical roles in maintenance of spermatogenesis and its loss
results in rapid and profound depletion of adult spermatogonia.
DDX5 is indispensable for the maintenance of spermatogonia.
Having demonstrated the requirement of DDX5 in maintenance
of spermatogonia in vivo, we sought to explore mechanisms
underlying DDX5 function and conﬁrm its cell-autonomous role
in the germline using an in vitro system4,14. Therefore, we
established cultures of undifferentiated spermatogonia from
untreated Ddx5TAM-KO mice and induced Ddx5 ablation by
treatment with 4-hydroxytamoxifen (TAM)12. Cultured
Ddx5TAM-KO spermatogonia treated with vehicle alone were used
as controls. Ddx5 was efﬁciently ablated in Ddx5TAM-KO sper-
matogonia following TAM and resulted in pronounced depletion
of cultured cells such that only few small colonies of PLZF-
positive Ddx5-ablated cells remained at D2 post-treatment
(Fig. 3a). These results are consistent with a critical cell-
autonomous role for DDX5 in spermatogonial maintenance. In
contrast, mouse embryonic ﬁbroblasts (MEFs) established
from Ddx5TAM-KO embryos and treated with TAM persisted in
culture and continued to proliferate despite loss of Ddx5
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Fig. 2 DDX5 is essential for the maintenance of spermatogenesis. a Adult mouse seminiferous tubule cross-sections showing tamoxifen-induced UBC-Cre-
mediated deletion of Ddx5 (Ddx5TAM-KO) results in loss of PLZF-positive spermatogonia by 7 days post-tamoxifen (D7) and all VASA-positive
spermatogenic cells by 30 days (D30). Only DDX5-retaining Sertoli cells are present at D30 in Ddx5TAM-KO seminiferous tubules. *: PLZF-positive
spermatogonia; ^: Sertoli cells; #: seminiferous tubules devoid of germ cells, with only DDX5-retaining Sertoli cells visible. b Adult mouse seminiferous
tubule whole mounts showing control and Ddx5TAM-KO tubules at D30 post-tamoxifen. Chains of PLZF-positive undifferentiated spermatogonia (red) are
clearly interspersed amongst Sertoli cells (visible by their characteristic pattern and morphology) in control tubules, whereas no spermatogonia are present
upon ablation of Ddx5. Zoom insets are shown for control (top middle) and Ddx5TAM-KO (bottom middle) conditions, as well as single channel images for
DDX5 (1), PLZF (2) and DAPI nuclear counterstain (3). All scale bars= 50 μm. c Gross testis morphology shows reduction of testis size in Ddx5TAM-KO
mice at D30 post-tamoxifen. d Quantiﬁcation of PLZF-positive cells per seminiferous tubule cross-section upon loss of Ddx5 at D5, D7, D14, and D30.
Control: n= 16 mice; D5: n= 5 mice; D7: n= 5 mice; D14: n= 5 mice; D30: n= 3 mice; Kruskal–Wallis test with Dunn’s multiple comparisons test. *P <
0.05; **P < 0.01; ***P < 0.001 all versus control. Mean ± SEM shown. e Comparison of body mass between control and Ddx5TAM-KO mice at D5, D7, D14,
and D30 post-tamoxifen shows no difference between conditions at any time point. D5: n= 4 mice control, n= 7 mice KO; D7: n= 6 mice control, n= 6
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suggesting a speciﬁc requirement for DDX5 within spermatogo-
nia (Fig. 3b). It was noted that expression of DDX17, a functio-
nally co-operative paralog of DDX526, was upregulated in Ddx5TAM-
KO MEFs following TAM when compared with vehicle-treated MEFs
(Fig. 3b, c). However, no corresponding increase in DDX17
was observed in Ddx5TAM-KO spermatogonia and although the
ratio of p72 and p82 isoforms appeared slightly altered upon
Ddx5 loss, this was not statistically signiﬁcant (Fig. 3b, c and
Supplementary Fig. 5). These data suggest that loss of DDX5
function in MEFs may be compensated for through upregulation
of DDX17, whereas its function is indispensable in
spermatogonia.
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Despite signiﬁcant loss of cultured spermatogonia upon Ddx5
ablation, we were able to extract RNA from remaining Ddx5-
ablated cells for gene expression analysis. TAM-treated and
vehicle-treated Ddx5TAM-KO spermatogonia were FACS-puriﬁed
at D2 based on expression of EpCAM to eliminate potential
feeder cell contamination12. We performed whole transcriptome
analysis using RNA-seq to gain insight into the consequences of
Ddx5 loss in undifferentiated spermatogonia. We found that
Ddx5 loss resulted in differential expression of 6934 genes (false
discovery rate <0.05) (Fig. 3d and Supplementary Data 2). We
conﬁrmed downregulation of Ddx5 in TAM-treated samples and
found aberrant expression of a number of key genes required for
maintenance and function of spermatogonia. Key stem-associated
and progenitor-associated genes such as Nanos2, Gfra1, Sohlh1,
Plzf (Zbtb16), and Gilz (Tsc22d3) were downregulated and these
changes conﬁrmed by RT-qPCR in independent samples (Fig. 3d,
Supplementary Fig. 6a and Supplementary Data 2). However, a
number of spermatogonia-associated and spermatogenesis-
associated genes were either upregulated (e.g., Rarg, Kit, Thy1,
T, Lhx1), downregulated (Nanos3, Rec8, Dnmt3b, Sycp3), or
unchanged (Sall4, Pou5f1), suggesting an overall dysregulation of
gene expression rather than transition to a particular state (e.g.,
stem, differentiating, meiotic induction) (Fig. 3d, Supplementary
Fig. 6a and Supplementary Data 2). We also noted upregulation
of Ddx17 in TAM-treated Ddx5TAM-KO spermatogonia by RNA-
seq analysis; however, this could not be conﬁrmed by RT-qPCR
and corresponding levels of DDX17 protein were unchanged
(Fig. 3b–d, Supplementary Fig. 5 and Supplementary Fig. 6a).
Moreover, the severity of Ddx5TAM-KO phenotype in spermato-
gonia indicates that DDX17 cannot compensate for DDX5
function in undifferentiated spermatogonia.
Concerning the general mechanism by which spermatogonia
were lost following Ddx5 ablation, we observed upregulation of
Trp53 and genes encoding effectors of p53-mediated apoptosis
(Bax, Puma, Noxa, Gadd45b)40,41 by RNA-seq analysis (Fig. 3e)
and we conﬁrmed upregulation of Puma and Gadd45b by RT-
qPCR in independent samples (Supplementary Fig. 6b). To
conﬁrm loss of Ddx5TAM-KO spermatogonia occurred by
apoptosis, we treated cells with TAM in combination with the
pan-caspase inhibitor, Z-VAD-FMK. At D2 post-treatment,
TAM-treated cells were almost completely lost, whereas sig-
niﬁcantly more cells remained when treated in combination with
Z-VAD-FMK. As expected, control cells treated with vehicle
alone or in combination with Z-VAD-FMK showed increased cell
numbers (Fig. 3f). By IF, we conﬁrmed successful gene ablation in
TAM-treated Ddx5TAM-KO spermatogonia under all conditions
and increased levels of apoptotic marker cleaved capsase-3
compared with controls (Fig. 3g). Importantly, we conﬁrmed
that the substantial increase in cleaved caspase-3-positive cells
evident upon Ddx5 deletion was inhibited by Z-VAD-FMK
(Fig. 3f, g). Although we could not conﬁrm upregulation of all
genes identiﬁed in our RNA-seq analysis by RT-qPCR, these data
indicate that following Ddx5 ablation, undifferentiated sperma-
togonia are lost due to p53-mediated apoptosis.
Next, we aimed to determine whether the helicase activity of
DDX5 is required for survival of spermatogonia, as previous
studies investigating the role of DDX5 in other systems have
shown helicase-dependent and independent functions22. We
transduced Ddx5TAM-KO cultured spermatogonia with lentiviral
constructs containing wildtype DDX5 (DDX5-WT) or a helicase-
inactive form of DDX542 (DDX5-NEAD) prior to TAM
treatment. Although we were unable to elicit expression of
DDX5 constructs to the same level as endogenous DDX5 and
observed substantial apoptosis in all conditions (Supplementary
Fig. 6c), we nevertheless observed ~5-fold higher cell numbers
remaining in the DDX5-WT condition and ~3-fold higher in the
DDX5-NEAD condition compared with control transduced cells
at D2 post-TAM (Fig. 3h). These ﬁndings suggest that although
the helicase activity of DDX5 is not entirely dispensable for
survival of undifferentiated spermatogonia, there exists a helicase-
independent function for DDX5 within spermatogonia. More-
over, Ddx5 is speciﬁcally required for survival of undifferentiated
spermatogonia, with its loss leading to aberrant expression of
spermatogonial genes and rapid induction of apoptosis.
DDX5 is required for splicing of key genes in spermatogonia.
DDX5 is involved in numerous transcriptional and post-
transcriptional gene regulatory processes across various biologi-
cal systems through interactions with other proteins21–24,26. To
gain additional insight into DDX5 function in undifferentiated
spermatogonia, we characterised DDX5 interacting proteins by IP
and MS analysis from lysates of cultured wildtype cells. We
identiﬁed 445 candidate proteins that interacted with DDX5
(Supplementary Data 3) and subjected these results to gene
ontology (GO) term overrepresentation analysis according to
classiﬁcation by molecular function and biological process using
PANTHER43. For GO molecular function and GO biological
Fig. 3 DDX5 is required for maintenance of undifferentiated spermatogonia in vitro. a Immunoﬂuorescence showing 4OH-tamoxifen-induced UBC-Cre-
mediated deletion of Ddx5 (Ddx5TAM-KO) results in loss of murine cultured undifferentiated spermatogonia by 2 days post-tamoxifen (D2). PLZF is used as
a marker of undifferentiated spermatogonia in culture and DAPI used as a nuclear counterstain (DNA). b Immunoﬂuorescence showing loss of Ddx5 in
cultured mouse embryonic ﬁbroblasts (MEFs) (Ddx5TAM-KO) results in a compensatory upregulation of DDX17 by D4 post-tamoxifen. *: representative
cells showing DDX5 loss and elevated DDX17. ^: DDX5-retaining MEFs with comparable levels of DDX17. c Representative western blots depicting DDX17
protein levels upon loss of Ddx5 in 4OH-tamoxifen-treated (TAM) MEFs and spermatogonia (Spg.) compared with vehicle-treated control (CTL) cells in a
tamoxifen-inducible cre/lox model (UBC-CreERT2;Ddx5ﬂox/ﬂox). Blots are representative of n= 4 independent experiments. d Volcano plot of differentially
expressed genes determined by RNA-sequencing analysis of vehicle-treated versus tamoxifen-treated Ddx5TAM-KO cultured spermatogonia. Dotted line
represents false discovery rate (FDR) cut-off <0.05. n= 4 biologically independent samples per condition. e Differentially expressed genes determined by
RNA-sequencing analysis related to p53-mediated apoptosis. #: indicates FDR <0.05. n= 4 independent samples per condition. Mean ± SEM shown.
f Quantiﬁcation of cell fold recovery following tamoxifen-induced Ddx5 ablation (Ddx5TAM-KO) in cultured spermatogonia at D2 versus vehicle-treated
control (Control) and effects of treatment with pan-caspase inhibitor Z-VAD-FMK (with DMSO used as a control). All differences between groups are
statistically signiﬁcant (P < 0.05, Mann–Whitney U test, n= 4 biologically independent cell lines per condition, mean ± SEM shown).
g Immunoﬂuorescence of cultured spermatogonia upon Ddx5 ablation at D1 depicting an increase in caspase-mediated apoptosis. Cleaved caspase-3
(cCASP3) is used as a marker of apoptotic cells, with SALL4 used as a marker of spermatogonia. Inhibition of apoptosis using the pan-caspase inhibitor Z-
VAD-FMK prevents loss of spermatogonia upon Ddx5 ablation. Nuclei are counterstained with DAPI (DNA). All scale bars= 100 μm. h Quantiﬁcation of
cell fold recovery at D2 in cultured murine spermatogonia transduced with wildtype DDX5 (WT), helicase-inactive mutant DDX5 (NEAD) or tdTomato
control constructs prior to tamoxifen-induced Ddx5 ablation at D0. *P < 0.05; n.s.: not signiﬁcant. Mann–Whitney U test, n= 4 biologically independent cell
lines per condition. Mean ± SEM shown
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process, we found signiﬁcant overrepresentation of terms related
to RNA binding and post-transcriptional processes, respectively
(Fig. 4a and Supplementary Data 4 and 5). To conﬁrm interac-
tions identiﬁed by MS analysis that implicate DDX5 in RNA
processing steps, we performed DDX5 IP from cultured wildtype
spermatogonia followed by western blot analysis. We conﬁrmed
interaction of DDX5 with ELAVL1 (mRNA stability), PABP1
(mRNA stability/export), and SRSF3 (splicing/mRNA export)
(Fig. 4b). Our data indicates that DDX5 is primarily involved in
RNA processing in undifferentiated spermatogonia.
Given these ﬁndings and that DDX5 is implicated in splicing
within other systems21,25,44, we sought to establish a role for
DDX5 in splicing within undifferentiated spermatogonia. We used
the MISO (mixture-of-isoforms) probabilistic framework45 to
analyse our RNA-seq data for identiﬁcation of alternative splicing
events upon loss of Ddx5. We discovered 667 alternative splicing
events upon loss of Ddx5 in spermatogonia (Bayes factor >10,
ΔPSI ≥0.20) with the majority of events (= 406/667) annotated as
cassette exon, where differential expression of speciﬁc exons was
identiﬁed between control and TAM-treated Ddx5TAM-KO
samples (Fig. 4c and Supplementary Data 6). From these events,
we selected candidates based on involvement in spermatogenesis
(Dazl, Ehmt2)46–48 and key cellular processes such as DNA repair/
homologous recombination (Rad50, Rad18)49,50 and autophagy
(Becn1)51. Loss of Ddx5 resulted in differential expression of exon
8 in Dazl (increased exon inclusion), exon 10 in Ehmt2 (increased
exon skipping), exon 15 in Rad50 (increased exon skipping), exon
10 in Rad18 (increased exon inclusion), and exon 3 in Becn1
(increased exon skipping) (Fig. 4d). We conﬁrmed these
candidates were bound to DDX5 by RNA immunoprecipitation
(RIP)-PCR (Fig. 4e), suggesting DDX5 is directly involved in their
splicing, and we validated these alternative splicing events by PCR
(Fig. 4f). Other candidates were conﬁrmed to be differentially
spliced upon Ddx5 loss (e.g., Fmr1) but were not detectably
bound to DDX5, suggesting their splicing is indirectly regulated
(Supplementary Fig. 7a–c). In addition, we conﬁrmed that Hprt
was not bound to DDX5 as a negative RIP control (Supplemen-
tary Fig. 7c).
Interestingly, the DNA repair genes Rad18 and Rad50 are
required for maintenance of spermatogenesis in mice and loss of
function of either gene results in infertility49,50. When we assessed
gene expression of mis-spliced candidates, we found Rad50 to be
substantially downregulated upon Ddx5 loss according to RNA-
seq (Fig. 4g), and we conﬁrmed this ﬁnding by RT-qPCR
(Supplementary Fig. 7d). By coding sequence analysis of Rad50
mRNA, we found that skipping of exon 15 results in the
introduction of a premature termination codon (Supplementary
Fig. 7e) and is likely to result in nonsense mediated decay of the
transcript52. Accordingly, we conﬁrmed a decrease in RAD50
protein in TAM-treated Ddx5TAM-KO spermatogonia compared
with controls by western blot (Fig. 4h) and IF (Fig. 4i). These
ﬁndings demonstrate that DDX5 is an important trans-acting
regulator of splicing in undifferentiated spermatogonia and its
loss results in dysregulated splicing of key genes required for
spermatogenesis. Moreover, p53-mediated apoptosis of sperma-
togonia following ablation of Ddx5 may be a direct consequence
of splicing defects53.
DDX5 regulates cyclin mRNA export and stability. To more
fully understand the transcriptional consequences of Ddx5 loss in
spermatogonia, we performed pathway analysis using the Inge-
nuity platform on differentially expressed genes identiﬁed by
RNA-seq. The top two pathways identiﬁed for top canonical
pathways and top tox lists (i.e., top biological “toxicity” associated
with the observed gene expression changes) were found to be cell
cycle-related pathways (Fig. 5a and Supplementary Data 7). We
observed aberrant expression of a number of genes involved in
cell cycle regulation upon Ddx5 ablation in spermatogonia,
including signiﬁcant upregulation of the cell cycle arrest gene
Cdkn1a (p21) (Fig. 5b and Supplementary Fig. 8a). However, core
cell cycle-related genes were not predicted to be aberrantly spliced
(Supplementary Data 6). Cell cycle analyses of surviving TAM-
treated Ddx5TAM-KO cells by ﬂow cytometry revealed a signiﬁcant
decrease in the proportion of cells in S-phase and an increase in
the proportion of cells in G2/M-phase compared with controls
(Fig. 5c). These data suggest that Ddx5 is speciﬁcally required in
undifferentiated spermatogonia to maintain the expression of
genes important for cell cycle and its loss results in cell cycle
arrest at both G1 and G2 checkpoints.
CCNA2 regulates G1/S and G2/M transitions of the cell cycle,
and is strongly expressed in spermatogonia54. Expectedly, given
decreased Ccna2 expression observed upon Ddx5 ablation, we
observed a decrease in CCNA2 level in TAM-treated cultured
Ddx5TAM-KO spermatogonia compared with controls (Fig. 5d, e
and Supplementary Fig. 8a). However, we noted that despite
arrest at both checkpoints, positive regulators of the cell cycle
such as Ccnd1 and Ccnd255 were upregulated in TAM-treated
Ddx5TAM-KO spermatogonia (Fig. 5b, c and Supplementary
Fig. 8a). When analysing protein levels, we found that CCND1
and CCND2 were decreased upon Ddx5 ablation in contrast to
respective mRNA levels (Fig. 5b, d, e), suggesting post-
transcriptional regulation of these genes was perturbed. To
investigate whether DDX5 was directly regulating cyclin expres-
sion post-transcriptionally, we performed RIP-qPCR in cultured
wildtype spermatogonia using an antibody against DDX5. We
analysed cyclin mRNAs that were differentially expressed
according to RNA-seq (Fig. 5b). For each transcript, we
determined fold enrichment versus pull down with immunoglo-
bulin G (IgG) control and found Ccnb2 (~70-fold), Ccnd1 (~40-
fold), Ccna2 (~30-fold), and Ccnd2 (~12-fold) to be the most
strongly enriched transcripts (Fig. 5f).
Given our observation of increased Ccnd1 and Ccnd2 mRNA
expression yet decreased levels of corresponding protein in Ddx5-
ablated spermatogonia, we considered that loss of DDX5 function
results in impaired nuclear export of these transcripts. Restricted
localisation of DDX5 to nuclei in spermatogonia (Fig. 1e)
together with binding of cyclin transcripts to DDX5 suggested
direct regulation of cyclin expression by post-transcriptional
processes other than translation. We assessed nuclear export of
Ccnd1 and Ccnd2 mRNA transcripts by determining nuclear-
cytoplasmic ratios at D2 post-TAM in cultured Ddx5TAM-KO
spermatogonia. We conﬁrmed signiﬁcant accumulation of both
Ccnd1 and Ccnd2 mRNA in the nucleus of Ddx5-ablated
spermatogonia (Fig. 5g), indicating that DDX5 directly regulates
export of these transcripts. In contrast, nuclear export of Ccna2
mRNA was not signiﬁcantly disrupted upon Ddx5 loss (Supple-
mentary Fig. 8b).
Ccna2 transcript is bound to DDX5 and both mRNA plus
protein levels of CCNA2 are downregulated upon Ddx5 loss,
suggesting a distinct mode of post-transcriptional regulation by
DDX5. Consequently, we assessed stability of Ccna2 mRNA upon
Ddx5 loss in Ddx5TAM-KO spermatogonia treated with the
transcription inhibitor actinomycin D. However, there was no
evident difference in Ccna2 mRNA stability between control and
TAM-treated samples (Fig. 5h), suggesting that Ccna2 down-
regulation occurs as an indirect transcriptional consequence of
Ddx5 ablation. Importantly, we observed a signiﬁcant reduction
in levels of Ccnb2 mRNA upon Ddx5 loss after 4 h of actinomycin
D treatment, indicating that stability of Ccnb2 transcript was
reduced (Fig. 5h). Given signiﬁcant reduction in Ccnb2 expres-
sion upon Ddx5 loss (Fig. 5b and Supplementary Fig. 8a) and
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association of Ccnb2 mRNA with DDX5, our results indicate that
the stability of Ccnb2 transcript is directly enhanced by DDX5.
We used Myc as an assay control and observed mRNA stability
comparable to previous reports in both control and TAM-treated
cells56 (Supplementary Fig. 8c).
These ﬁndings demonstrate that DDX5 is required for post-
transcriptional regulation of cyclin mRNAs in undifferentiated
spermatogonia. Furthermore, that cell cycle arrest observed upon
Ddx5 loss is, at least in part, a consequence of impaired export
and stability of speciﬁc cyclin transcripts.
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ILF3 associates with DDX5 and regulates CCND1 expression.
While investigating the role of DDX5 in cell cycle regulation in
spermatogonia, we identiﬁed and conﬁrmed interaction of DDX5
with ILF3 and its protein partners ILF2 and IGF2BP357,58 (Fig. 4b
and Supplementary Data 3). ILF3 (interleukin enhancer binding
factor 3, also known as NF90 or NFAR) is an RNA-binding
protein important for transcriptional and post-transcriptional
regulation of Il2 in T cells and plays key regulatory roles in cell
cycling58–61.
In light of the identiﬁed functional connection between DDX5
and ILF3, we examined protein expression of ILF3 in male
germline cells by IF. We observed ILF3 expression in all PLZF-
positive cultured undifferentiated spermatogonia (Fig. 6a), as well
as in vivo co-localisation with DDX5 in the nucleus of
spermatogonia, spermatocytes, spermatids, and Sertoli cells of
mouse seminiferous tubules (Fig. 6b). Previous studies have
demonstrated that ILF3 is involved in post-transcriptional
regulation of cyclin mRNAs57,62. Therefore, we performed ILF3
RIP-qPCR experiments in cultured wildtype spermatogonia to
identify cyclin mRNAs bound to ILF3 and elucidate a potential
co-regulatory role with DDX5. We found strong enrichment of
Ccnb2 (~1124-fold), Ccna2 (~718-fold), Ccnd1 (~84-fold), Ccne1
(~73-fold), and Ccnd2 (~62-fold) transcripts (versus IgG control),
whereas others such as Ccnd3 and Ccna1 showed minimal
enrichment or did not appear to be bound to ILF3, respectively
(Fig. 6c).
ILF3 regulates the stability of Ccne1 mRNA by direct binding
to its 3’-UTR and post-transcriptionally regulates Ccnd1 through
interactions with IGF2BP357,62. Given the DDX5/ILF3 interac-
tion and known role of ILF3 in cyclin transcript regulation, we
sought to determine whether loss of Ilf3 in undifferentiated
spermatogonia would result in a phenotype similar to that
observed upon loss of Ddx5. We therefore used a lentiviral
doxycycline (DOX)-inducible CRISPR/Cas9 system63 to ablate
Ilf3 in cultured wildtype spermatogonia (referred to as Ilf3–/–
cells). At D4 post-DOX treatment, we conﬁrmed loss of Ilf3 by
RT-qPCR and at the protein level by IF and western blot (Fig. 6d,
f, g). In contrast to Ddx5 loss, Ilf3–/– spermatogonia persisted in
culture and continued to proliferate. However, we observed a
signiﬁcantly reduced growth rate of Ilf3–/– cells compared with
DOX-treated wildtype cells when analysed D2 post-treatment
(Fig. 6d, e). Analysis of gene expression in Ilf3–/– spermatogonia
by RT-qPCR did not ﬁnd any signiﬁcant change in expression of
analysed cyclin genes compared with controls (Fig. 6f). However,
CCND1 protein was substantially decreased upon loss of Ilf3
(Fig. 6g); a phenotype analogous to observed Ccnd1 mRNA
export defects upon Ddx5 loss. However, we were unable to
conﬁrm consistent changes in Ccnd1 nuclear-cytoplasmic ratio
upon Ilf3 loss, suggesting alternate post-transcriptional regulatory
mechanisms are in play (Supplementary Fig. 9).
The difference in severity of cellular phenotypes and disruption
in cyclin expression upon loss of Ddx5 and Ilf3 suggests that
regulation of cyclin genes in undifferentiated spermatogonia and
consequent effects on cell cycling are not dependent on a DDX5/
ILF3 complex. Rather, DDX5-dependent post-transcriptional
regulation is important for cyclin mRNA expression and cell
cycle regulation whereas ILF3 appears dispensable, with the
exception of Ccnd1.
DDX5 and PLZF share DNA binding sites and co-regulate Ilf3.
Previous studies in other systems have shown that DDX5 inter-
acts with and modulates activity of transcriptional regulators
including MYOD, RUNX2, the tumour suppressor p53, and
oestrogen receptor alpha22. Considering the ability of DDX5 to
interact with transcription factor PLZF (Fig. 1b), we investigated
whether DDX5 acts as a PLZF co-factor in undifferentiated
spermatogonia. We therefore performed ChIP-sequencing (ChIP-
seq) for DDX5 on cultured wildtype undifferentiated spermato-
gonia and identiﬁed 101 putative binding sites, of which 31 were
found within gene promoter regions (Fig. 7a and Supplementary
Data 8). Motif analysis of bound regions identiﬁed enrichment of
the E-box-containing CLEAR element (5’-GTCACGTGAC-3’), a
binding motif for the autophagy regulator TFEB64 (Fig. 7b).
Amongst our ChIP-seq analysis, we found DDX5 bound within
the promoter regions of autophagy-related genes Lamp1, Gns,
Hexa, Tmem55b, and Atp6v1h (Fig. 7c). Of these genes, only
Hexa (1.12-fold downregulated), Tmem55b (1.13-fold upregu-
lated), and Atp6v1h (1.15-fold upregulated) were differentially
expressed according to RNA-seq analysis in cultured Ddx5-
ablated spermatogonia compared with controls (false discovery
rate <0.05) (Fig. 7d); however, these minor changes could not be
conﬁrmed by RT-qPCR (Supplementary Fig. 10d). Furthermore,
we were unable to establish an interaction between DDX5 and
TFEB by co-IP, indicating that DDX5 is unlikely to be a TFEB co-
factor (Supplementary Fig. 10a). Therefore, while recruitment of
DDX5 to CLEAR motifs is compelling, our data indicate that
Fig. 4 DDX5 is an essential regulator of splicing in undifferentiated spermatogonia. a Gene ontology (GO) term enrichment analysis of data obtained from
DDX5 immunoprecipitation followed by mass spectrometry using wildtype murine cultured undifferentiated spermatogonia (n= 3 independent
experiments). b DDX5 immunoprecipitation followed by western blot in wildtype cultured spermatogonia conﬁrming the interaction of DDX5 with proteins
involved in pre-mRNA splicing (SRSF3), maintenance of mRNA stability (ELAVL1, PABP1, ILF3, ILF2, IGF2BP3), mRNA export (PABP1, SRSF3, ILF2, ILF3,
IGF2BP3) and translation (IGF2BP3). Representative of n= 2 independent experiments. c Summary of differential splicing analysis performed between
control and Ddx5-ablated cultured spermatogonia. Numbers of predicted alternative splicing events in each category upon Ddx5 deletion are indicated.
d Visualisation of differential splicing analysis of RNA-sequencing data comparing control and Ddx5-ablated spermatogonia. Tracks are shown for selected
candidate genes (left). Red arrows indicate differentially spliced exon. Schematics of alternative splicing events are shown (blue and yellow rectangles)
(middle). Change in “percent spliced in” between conditions is shown as a value below splicing schematics (ΔPSI) and in bar charts (right). #: changes
meet analysis cut-offs (ΔPSI >0.20, Bayes Factor ≥10). PSI ± 95% conﬁdence interval shown. e RNA-immunoprecipitation using DDX5 antibody in cultured
wildtype spermatogonia followed by PCR and gel electrophoresis for differentially spliced candidates depicted in d. Representative of n= 3 independent
samples per condition. f PCR validation of differentially spliced candidates identiﬁed in d. CTL vehicle-treated control spermatogonia, KO Ddx5-ablated
cultured spermatogonia. Differentially spliced exons are depicted by “Δexon number”. Representative of n= 3 independent samples. Position of the PCR
primers used are depicted in d in orange beneath schematic showing gene structure. g Bar chart of RNA-sequencing analysis for selected candidates. Fold
change in Ddx5-ablated spermatogonia relative to vehicle-treated control. # denotes FDR <0.05. Mean ± SEM shown; n= 4 independent biological
replicates per condition. h RAD50 protein levels by western blot in vehicle-treated control (Control) versus Ddx5-ablated cultured spermatogonia
(Ddx5TAM-KO). *P < 0.05; two-tailed unpaired t-test; mean ± SEM shown; n= 4 independent biological replicates per condition. Representative western blot
shown on right. i RAD50 immunoﬂuorescence of vehicle-treated control (top) and Ddx5-ablated (bottom) cultured spermatogonia at D2 post-treatment.
Representative of n= 4 independent biological replicates per condition. Scale bars= 100 μm
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DDX5 is not an essential transcriptional regulator of autophagy-
related genes in spermatogonia.
To investigate the potential role of DDX5 as a PLZF
transcriptional co-factor in spermatogonia, we compared DDX5
ChIP-seq and RNA-seq datasets to identify DDX5-bound genes
differentially expressed upon Ddx5 loss. Forty-nine genes were
potentially transcriptionally regulated by DDX5, with the number
of upregulated and downregulated genes (25 versus 24,
respectively) suggesting DDX5 may act as both an activator and
repressor of transcription (Fig. 7e and Supplementary Fig. 10b, c).
Next, we compared these 49 genes with a published PLZF ChIP-
seq study16 to identify shared binding sites. We found DDX5 and
PLZF overlapping binding sites within promoter regions of
Amdhd2, Ilf3, Arhgap12, Tmem55b, 4933434E20Rik, and Zbtb25
(Fig. 7f and Supplementary Data 8). Next, we determined changes
in expression of these genes according to RNA-seq and found
signiﬁcant downregulation of Amdhd2 (1.53-fold), Ilf3 (1.44-
fold), and Arhgap12 (1.31-fold), and upregulation of Tmem55b
(1.13-fold, as described earlier), 4933434E20Rik (1.16-fold) and
Zbtb25 (1.24-fold) upon Ddx5 loss. However, only changes in Ilf3
and Amdhd2 expression could be conﬁrmed by RT-qPCR (Fig. 7d,
g and Supplementary Fig. 10e). We examined expression of these
DDX5-bound and PLZF-bound genes in undifferentiated sper-
matogonia isolated from testes of Plzf-null mice as described11,12.
However, from this panel of genes only Ilf3 was signiﬁcantly
downregulated in Plzf-null cells compared with wildtype controls
(Fig. 7h). We identiﬁed DDX5 binding to the promoter of Ilf3 as
one of the top peaks by ChIP-seq and conﬁrmed that this site
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overlapped with a previously identiﬁed PLZF-binding site
(Fig. 7i). In addition to downregulation of Ilf3 mRNA, we found
reduced levels of ILF3 protein at D2 in TAM-treated versus
vehicle-treated Ddx5TAM-KO spermatogonia (Fig. 7j).
Finally, we performed siRNA-mediated Plzf knockdown in
cultured spermatogonia (with non-targeting siRNA used as
control) followed by DDX5 ChIP-qPCR to determine whether
DDX5 recruitment to gene promoters was PLZF-dependent. First,
we conﬁrmed efﬁcient Plzf knockdown by western blot
(Supplementary Fig. 11a). Next, we performed DDX5 ChIP in
control versus Plzf knockdown spermatogonia and determined
enrichment by qPCR for peak regions identiﬁed by DDX5
and PLZF ChIP-seq16 (Supplementary Fig. 11b). We selected
candidate PLZF-DDX5 co-regulated genes Ilf3, Amdhd2
and Lamp1 for analysis, plus uniquely DDX5-bound and PLZF-
bound genes Zmym6 and Tex13b16, respectively, as controls.
However, we found no difference in DDX5 enrichment at Ilf3,
Amdhd2 and Lamp1 promoters between control and Plzf siRNA
conditions, suggesting that DDX5 recruitment to these target
genes is PLZF-independent (Supplementary Fig. 11c).
We conclude that while DDX5 and PLZF are both bound at the
Ilf3 promoter and co-regulate Ilf3 expression, other factors
besides PLZF mediate DDX5 recruitment to this gene. Further-
more, our data indicates that DDX5 is a multifaceted regulator of
ILF3 function given its association with the ILF3/ILF2/IGF2BP3
protein complex and ability to regulate Ilf3 expression.
Discussion
Spermatogenesis is a complex process dependent on the co-
ordinated regulation of gene expression at transcriptional and
post-transcriptional levels1. It has been demonstrated that the
transcription factor PLZF is important for self-renewal of
undifferentiated spermatogonia, the population of adult stem and
progenitor cells that enable lifelong male fertility11,14. More
recently, the role of various RNA-binding proteins during sper-
matogenesis has been uncovered, particularly during meiotic
and post-meiotic stages of spermatogenesis where periods
of transcriptional quiescence demand mechanisms for
post-transcriptional control of gene expression1. However, few
RNA-binding factors with speciﬁc functions in undifferentiated
spermatogonia have been identiﬁed. NANOS219, DND165, and
BCAS220 have been described as important RNA-binding pro-
teins within undifferentiated spermatogonia and each has a
unique role in post-transcriptional regulation, highlighting the
complexity of this process and the need for further investigation.
In this study, we have identiﬁed an interaction between PLZF
and the RNA helicase DDX5. We demonstrate that DDX5 is
expressed throughout the male germline and its loss has cata-
strophic effects on spermatogenesis. Using a murine knockout
model, we show that Ddx5 ablation results in rapid loss of
spermatogonia in vivo and in vitro. Moreover, we demonstrate
that Ddx5 ablation causes aberrant expression of genes involved
in maintenance of spermatogonia, cell cycle, and apoptosis. Ddx5
is particularly essential for spermatogonial function; the inducible
Cre driver used to delete Ddx5 in vivo is active in multiple tis-
sues38, yet TAM-treated Ddx5TAM-KO mice did not display any
overt phenotype besides germline depletion.
While a speciﬁc role for DDX5 within the male germline has
not been described previously, a study detailed DDX5 expression
in subsets of spermatogenic cells in humans30. Consistent with
this study, we identiﬁed robust expression of DDX5 in PLZF-
positive spermatogonia of humans and non-human primates
although DDX5 was also detected in spermatocytes, spermatids,
and somatic cell populations within the testis. We observed a
ubiquitous expression of Ddx5 in testis cells of mice and previous
studies also identiﬁed DDX5 within other murine spermatogenic
cell types31, conﬁrming its broad expression within the testis.
Nevertheless, expression of DDX5 in primate spermatogonia
suggests that the essential role of DDX5 in mouse spermatogonial
maintenance is conserved in other mammalian species.
In this study, we observed signiﬁcant loss of spermatogonia
upon ablation of Ddx5 both in vivo and in vitro. In contrast, Ddx5
appeared dispensable within ﬁbroblasts and its loss potentially
compensated for by upregulation of the related helicase DDX1726.
Previous studies have identiﬁed functional redundancy between
DDX5 and DDX17 in regulation of splicing, ribosome biogenesis,
cell proliferation, and transcriptional co-activation21–23,26,27.
However, studies employing individual knockdown of Ddx5 and
Ddx17 have also provided evidence for non-overlapping roles22.
For example, DDX5 is important for the p53-mediated DNA
damage response in cancer cell lines, whereas Ddx17 knockdown
had no effect on this process42. Although Ddx17 expression is
detected in undifferentiated spermatogonia and upregulated at
the transcript level upon Ddx5 deletion according to RNA-seq,
our ﬁndings support a critical role for DDX5 in spermatogonia
that evidently cannot be compensated for by DDX17.
Through MS analysis, we have shown that DDX5 interacts with
a number of proteins involved in post-transcriptional gene reg-
ulatory processes including pre-mRNA splicing, maintenance of
mRNA stability, and mRNA export. Although the role of DDX5
in these processes is somewhat appreciated from other
Fig. 5 DDX5 regulates cell cycle progression in spermatogonia post-transcriptionally. a Pathway analysis of differentially expressed genes identiﬁed by
RNA-sequencing comparing control and Ddx5-ablated cultured spermatogonia. b Differentially expressed cell cycle-related genes identiﬁed by RNA-
sequencing comparing control and Ddx5-ablated cultured spermatogonia. Fold change in Ddx5-ablated spermatogonia shown relative to control. Mean ±
SEM shown; n= 4 independent biological replicates per condition. # denotes FDR <0.05. c Representative ﬂow cytometry plots (left) showing Ddx5 loss
results in cell cycle arrest in cultured undifferentiated spermatogonia at D1 post-ablation. Control: vehicle-treated control spermatogonia; Ddx5TAM-KO:
tamoxifen-induced Ddx5-ablated spermatogonia. Representative of n= 3 independent experiments. Histogram (right) depicts quantiﬁcation of cell
proportions for each cell cycle phase determined by ﬂow cytometry. *P < 0.05; **P < 0.01. Two-tailed unpaired t-test, n= 3 independent experiments per
condition. d Representative western blot showing reduced CCNA2, CCND1 and CCND2 protein upon loss of Ddx5 (Ddx5TAM-KO) compared with control in
cultured undifferentiated spermatogonia at D2 post-tamoxifen treatment. Representative of n= 3 independent experiments. e Quantiﬁcation of western
blots represented in d. Mean ± SEM shown; *P < 0.05; **P < 0.01; Two-tailed unpaired t-test. n= 4 independent samples per condition. f RNA
immunoprecipitation using DDX5 antibody in cultured wildtype undifferentiated spermatogonia followed by RT-qPCR for cyclin genes. Fold enrichment
versus IgG control shown. Mean ± SEM shown; n= 2 independent experiments. g Nuclear-cytoplasmic ratio of Ccnd1 and Ccnd2 transcripts determined by
RT-qPCR of control and Ddx5-ablated (Ddx5TAM-KO) cultured undifferentiated spermatogonia subcellular fractions. Fold change relative to control shown.
Mean ± SEM shown; *P < 0.05; Mann–Whitney U test; n= 4 independent samples per condition. h Analysis of mRNA stability over time following inhibition
of transcription by actinomycin D treatment in control versus Ddx5-ablated (Ddx5TAM-KO) cultured undifferentiated spermatogonia. mRNA expression
determined by RT-qPCR (normalised to Actb) relative to initial levels at time 0 h. *P < 0.05; Two-way ANOVA with Bonferroni multiple comparisons test;
mean ± SEM shown; n= 4 independent samples per condition
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systems21,24,29, it is well known that cell type-speciﬁc post-tran-
scriptional regulation occurs and defects in ubiquitously expres-
sed RNA-binding proteins can lead to disease phenotypes within
speciﬁc tissues66. Here, we have identiﬁed an essential post-
transcriptional regulator in spermatogonia that acts at multiple
stages of RNA processing.
Our results support an essential role for DDX5 in splicing
regulation within spermatogonia. It is known that splicing can be
regulated in a tissue-speciﬁc manner and mediators of alternative
splicing within the testis have been described1,67. We propose that
DDX5 is central to the maintenance of an appropriate splicing
programme through interactions with other known splicing
regulators in spermatogonia and its loss leads to aberrant splicing
of key spermatogenic and cellular genes. These splicing defects
are likely to result in severely compromised gene expression or
the translation of inappropriate protein isoforms, which may
account for the rapid loss of spermatogonia observed upon Ddx5
ablation.
Interestingly, we found the important germ cell genes Dazl and
Ehmt2 to be aberrantly spliced in Ddx5-ablated spermatogonia,
similar to a recent study that identiﬁed a role for BCAS2 in
splicing within spermatogonia20. Dazl encodes an RNA-binding
protein essential for germ cell maintenance and meiotic induc-
tion46 and knockout mice are known to be infertile48. Our results
indicate that Ddx5 loss results in decreased levels of the Dazl-Δ8
isoform. To our knowledge, a role for Dazl-Δ8 in the male
germline has not been deﬁned. However, Dazl-Δ8 binds unique
targets in mouse embryonic stem cells;68 therefore, its loss may
have important consequences in spermatogonia that warrants
further investigation. Similarly, a speciﬁc role for Ehmt2-Δ10 in
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NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-09972-7 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:2278 | https://doi.org/10.1038/s41467-019-09972-7 | www.nature.com/naturecommunications 13
male germ cells is unknown, although the role of Ehmt2 as an
essential epigenetic regulator during embryogenesis and sper-
matogenesis is deﬁned47. A distinct role for Ehmt2-Δ10 is
described in neuronal differentiation69, suggesting additional
roles in other systems may yet be uncovered.
In addition to Dazl and Ehmt2, we found that DDX5 was
important for the splicing of double-strand break (DSB) repair
genes Rad18 and Rad50. It is known that DSB repair is pivotal for
meiotic homologous recombination70 and both Rad18 and Rad50
mutant mice are infertile due to spermatogenic defects49,50.
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Rad18 and Rad50 are expressed in spermatogonia and sperma-
togenic failure in these models is suggested to be due to impaired
spermatogonial stem cell maintenance and pre-meiotic defects,
respectively49,50. Therefore, aberrant splicing of these genes in
Ddx5-ablated spermatogonia leading to impaired protein func-
tion or expression likely results in deleterious effects. We also
found aberrant splicing of Becn1, an important regulator of
autophagy51. Although a speciﬁc role for Becn1 in spermatogonia
has not been deﬁned, autophagy is a critical cellular process that
is important throughout spermatogenesis during normal and
pathological conditions71.
Importantly, major spliceosome defects are suggested to be
associated with non-obstructive azoospermia in humans and
prevent spermatogonial differentiation in Drosophila72. Disrup-
tion of the pre-mRNA splicing machinery is known to result in
p53 activation, p21 upregulation and cell cycle arrest in G1
phase53, all of which were observed within Ddx5-ablated sper-
matogonia in our study. Therefore, the rapid and signiﬁcant
apoptosis of spermatogonia that occurs upon Ddx5 loss may also
be due to its role as core spliceosome component. However, we
suggest that the negative effects of Ddx5 deletion on cell pro-
liferation are due to defects in speciﬁc DDX5-mediated post-
transcriptional regulatory mechanisms.
We found that loss of Ddx5 in spermatogonia results in cell
cycle arrest at both G1/S and G2/M stages. Several cell cycle-
related genes were aberrantly expressed, including strong upre-
gulation of Cdkn1a (p21), a negative regulator of the G1/S
checkpoint. Interestingly, we found a number of cyclin mRNA
transcripts bound to DDX5 and showed that nuclear export and
stability of a subset of these were regulated by DDX5. Ccnd1 and
Ccnd2 transcripts were retained aberrantly in the nucleus upon
Ddx5 ablation and protein levels were signiﬁcantly reduced. It has
been shown that RNA-binding proteins can have roles in splicing
and mRNA nuclear export of different transcripts within a single
cell type that contributes to overall cellular function56. Besides
their general requirement for G1/S-phase progression54, CCND1
and CCND2 are dynamically regulated during spermatogenesis
and are predominately expressed in speciﬁc subsets of sperma-
togonia. CCND2 has been shown to be important for long-term
maintenance of spermatogonial stem cell self-renewal73, whereas
Ccnd1 expression is predominantly associated with differentiating
subsets of spermatogonia37. Therefore, we suggest that impaired
spermatogonial function as a result of CCND1 and CCND2 loss
may contribute to the overall Ddx5-knockout phenotype in
addition to expected effects on G1/S-phase transition. Impor-
tantly, we demonstrate that DDX5 is required for efﬁcient nuclear
export of these transcripts and maintenance of CCND1 and
CCND2 protein in spermatogonia.
We found that DDX5 bound to Ccna2 and Ccnb2 transcripts in
spermatogonia and these genes were downregulated upon Ddx5
ablation. Ccna2 is expressed strongly in spermatogonia and is
required for progression through G1/S and G2/M checkpoints,
whereas CCNB2 functions only at the G2/M transition54. The
binding of DDX5 to these transcripts and its absence at Ccna2
and Ccnb2 promoters by ChIP-seq coupled with differential
expression upon Ddx5 loss suggests a post-transcriptional reg-
ulatory role; however, we did not ﬁnd defects in mRNA export or
transcript stability of Ccna2 in Ddx5-ablated spermatogonia. We
suggest that Ccna2 downregulation is an indirect transcriptional
consequence but nevertheless can contribute to the G2/M arrest
observed in spermatogonia upon Ddx5 loss. We cannot exclude
that other RNA-binding proteins are involved in maintaining the
stability of particular transcripts, either independently or in
association with DDX5. For example, we found DDX5 interacts
with ELAVL1 in spermatogonia and this protein is known to be
important for maintenance of mRNA stability through 3’-UTR-
mediated interactions74. In contrast, we found that the stability of
Ccnb2 mRNA was signiﬁcantly reduced in Ddx5-ablated sper-
matogonia and Ccnb2 was strongly downregulated compared
with control spermatogonia. Given its central importance in G2/
M transition, we propose that decreased Ccnb2 transcript stability
is a main contributor to G2/M cell cycle arrest we observe in
Ddx5-ablated spermatogonia.
Notably, we found that DDX5 interacts with ILF3, a post-
transcriptional regulator of cyclin mRNA transcripts57,58,62, and
demonstrated that ILF3 associates with cyclin mRNAs in sper-
matogonia. While expression of cyclins at the mRNA level
appeared unaffected upon Ilf3 deletion, CCND1 protein was
substantially reduced and cell growth inhibited. This indicates
that ILF3 is involved in post-transcriptional regulation of Ccnd1
and plays a role in cell cycle regulation alongside DDX5. A spe-
ciﬁc role for ILF3 has not been described in spermatogonia;
however, its role in cyclin regulation and cell cycle progression
has been shown in other systems, with ILF3 acting independently
or in concert with binding partners ILF2 and IGF2BP357–59,62.
Our data indicates that DDX5 is present in a complex with
ILF3, ILF2, and IGF2BP3 and that together they bind a number of
cyclin mRNA transcripts. However, whether this complex is
absolutely required for regulation of expression of these mRNAs
remains unclear as independent ablation of Ddx5 and Ilf3 did not
produce overlapping effects on gene expression, with the excep-
tion of Ccnd1. Both DDX5 and ILF3 evidently regulate Ccnd1
post-transcriptionally, although the role of DDX5 appears more
signiﬁcant. Given ﬁndings of this study and previously described
functions of DDX5 and ILF3, our observation of increased or
unchanged cyclin mRNA expression yet decreased protein levels
suggests disruption of mRNA nuclear export or translation
mechanisms. Defects in translation of cyclin mRNAs may be
unlikely, as both DDX5 and ILF3 appear exclusively nuclear
within spermatogonia. However, DDX5 and ILF3 evidently
function through different post-transcriptional mechanisms;
therefore, further studies are required to deﬁne the signiﬁcance of
DDX5-ILF3 interaction and precise post-transcriptional
mechanisms by which ILF3 controls cyclin expression in
spermatogonia.
Besides its known roles in RNA processing, previous studies
have identiﬁed DDX5 as a co-factor of transcriptional
regulators21,22. The ability of DDX5 to interact with PLZF indi-
cated that DDX5 is a transcriptional co-factor for PLZF in
spermatogonia. Through ChIP-seq experiments, we found that
DDX5 is present at a number of gene promoters overlapping with
previously identiﬁed PLZF binding sites16, including that of Ilf3.
Individual loss of Ddx5 and Plzf in spermatogonia resulted in
reduced llf3 expression, suggesting a co-ordinated role in reg-
ulation of Ilf3 expression. We propose that PLZF/DDX5-depen-
dent expression of Ilf3 is required in part to maintain proliferative
capacity of undifferentiated spermatogonia through post-
transcriptional regulation of cell cycle-related genes such as
Ccnd1. Interestingly, despite robust interaction between PLZF
and DDX5 in cultured undifferentiated spermatogonia, DDX5 is
only recruited to a small subset of PLZF target genes. Molecular
mechanisms mediating selective association of DDX5 with PLZF
at speciﬁc target genes remain unclear and DDX5 recruitment to
PLZF-target gene promoters was not strictly dependent on PLZF,
suggesting its recruitment is mediated through other factors. For
example, DDX5 can interact with RNA polymerase II and is
suggested to function as a link between transcriptional and post-
transcriptional processes75. Notably, we found RNA polymerase
subunits within our list of DDX5 interacting proteins identiﬁed
by IP-MS, suggesting this mechanism may be conserved in
spermatogonia. This suggests that the described association of
DDX5 with multiple transcriptional regulators across distinct
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systems may occur due to a broader role in transcription initia-
tion and/or elongation. Accordingly, DDX5 (in association with
DDX17) is important for formation of the transcription initiation
complex (including recruitment of RNA polymerase II) at pro-
moters of skeletal muscle-related genes27. It is conceivable that
this mechanism is conserved in other cell systems and dependent
on tissue-speciﬁc transcriptional regulators that bind proximal
promoter elements. Although PLZF was found unnecessary for
recruitment of DDX5 to shared target gene Ilf3, such recruitment
may be dependent on other transcriptional regulators that are yet
to be characterised. Motif analysis of our DDX5 ChIP-seq dataset
suggests that E-box binding proteins are likely candidates and
numerous E-box binding motifs are found within the Ilf3 prox-
imal promoter. Nevertheless, our data indicate that PLZF and
DDX5 interact at the Ilf3 promoter and are both required for its
appropriate expression in spermatogonia. Given that transcrip-
tion regulation-independent roles for PLZF have been descri-
bed76, it is also possible that the interaction of PLZF with DDX5
is relevant for non-transcriptional PLZF functions. Notably, the
majority of genes dysregulated upon loss of Ddx5 in spermato-
gonia are not bound by either DDX5 or PLZF and are not dif-
ferentially spliced according to our analyses. This indicates that
loss of Ddx5 results in many indirect transcriptional con-
sequences. The even distribution of upregulated and down-
regulated genes upon Ddx5 loss in SPCs precludes a global defect
in mRNA stability.
The TFEB transcription factor is a master regulator of lyso-
some biogenesis and autophagy and binds target promoters
through the CLEAR sequence motif64. Our ChIP-seq analysis
found DDX5 bound to promoters of multiple TFEB target genes
in cultured undifferentiated spermatogonia and the CLEAR
sequence element was enriched at DDX5 binding sites. However,
we were unable to conﬁrm a speciﬁc role for DDX5 as a co-factor
of TFEB and transcriptional regulator of autophagy-related genes.
One exception could be Amdhd2, a PLZF target gene that was co-
bound by DDX5 and is a candidate TFEB target77. Amdhd2 is
involved in amino sugar metabolism but despite potential reg-
ulation by TFEB, speciﬁc roles in autophagy or lysosome function
are unexplored78. Moreover, while Amdhd2 was signiﬁcantly
downregulated upon Ddx5 deletion, whether DDX5 promoted
Amdhd2 expression by acting as a co-factor of TFEB rather than
PLZF remains to be determined. Notably, we found that DDX5
regulates splicing of the autophagy-associated gene Becn1 sug-
gesting DDX5 may play a multifaceted role in autophagy. These
ﬁndings can form the basis of future studies investigating addi-
tional mechanisms of autophagy regulation.
Considering our data demonstrating the role of DDX5 in
splicing, mRNA export and transcript stability, as well as
recruitment to multiple gene promoters, we propose a model
whereby DDX5 maintains function of undifferentiated sperma-
togonia by regulating gene expression programmes through
multiple distinct mechanisms (Fig. 8). Speciﬁcally, that DDX5
plays essential roles in post-transcriptional gene regulation as a
trans-acting mediator of splicing and through regulation of
mRNA stability and export independently and via interactions
with other RNA-binding proteins such as ILF3. Furthermore, we
propose that DDX5 and PLZF co-regulate transcription of Ilf3,
thereby maintaining cell cycle progression through downstream
effects on cyclin mRNA transcripts (Fig. 8). However, given that
DDX5 recruitment to the Ilf3 promoter does not appear to be
dependent on PLZF, further study is required to conﬁrm sig-
niﬁcance of the DDX5-PLZF interaction or identify other tran-
scriptional regulators mediating DDX5 recruitment.
In conclusion, our study provides evidence of an essential role
for Ddx5 during in vivo spermatogenesis and in maintenance of
spermatogonia. Moreover, through a combination of MS and
ChIP-seq approaches, we provide evidence for undeﬁned tran-
scriptional roles and identify DDX5 molecular targets. Altogether,
our ﬁndings present DDX5 as a multidimensional regulator of
gene expression in spermatogonia and an essential factor for male
fertility. Given that mammalian spermatogenesis is an ideal
model for the study of adult stem cells, an understanding of the
important factors and mechanisms governing this process may
have implications beyond reproductive biology.
Methods
Mouse maintenance and treatment. Ddx5ﬂox/ﬂox and Plzf –/– mice were estab-
lished in previous studies11,39. UBC-CreERT2 mice38 were obtained from the
Jackson Laboratory. For in vivo gene deletion experiments, 8-week-old to 12-week-
old male mice were injected with 2 mg tamoxifen (Sigma-Aldrich) dissolved in a
90% sesame oil (Sigma-Aldrich)/10% ethanol vehicle solution for 2 consecutive
days12. All animal experimentation was conducted in accordance with institutional
ethical requirements and approved by the Monash University Animal Ethics
Committee.
Whole mount and frozen section immunoﬂuorescence. For immuno-
ﬂuorescence staining of whole mount samples, testes were detunicated and semi-
niferous tubules washed in ice cold phosphate-buffered saline (PBS). Tubules were
ﬁxed with 4% paraformaldehyde (PFA) for 6 h and washed with PBS prior to
blocking with 10% v/v foetal bovine serum (FBS) (In Vitro Technologies), 2% w/v
bovine serum albumin (BSA) (Sigma-Aldrich) and 0.3% v/v Triton X-100 (Sigma-
Aldrich) in PBS. Tubules were incubated overnight at 4 °C with primary antibodies
diluted in PBS supplemented with 0.3% v/v Triton X-100 and 1% w/v BSA. Tubules
were washed with PBS supplemented with 0.3% v/v Triton X-100. Tubules were
then incubated for one hour at room temperature with Alexa Fluor-conjugated
secondary antibodies diluted in PBS supplemented with 0.3% v/v Triton X-100 and
1% w/v BSA.
To prepare frozen sections, testes were ﬁxed in 4% PFA for 24 h at 4 °C, washed
in PBS and incubated in 30% w/v sucrose solution for 48 h at 4 °C. Testis samples
were placed in Optimum Cutting Temperature compound (OCT) (Sakura Finetek)
and frozen at -80 °C then sectioned using a cryostat. For frozen section
immunoﬂuorescence, 8 μm thick testis cross-sections were washed in PBS and
blocked for 1 h at room temperature with 10% v/v FBS and 2% w/v BSA in PBS
(block solution). Sections were incubated overnight at 4 °C with primary antibodies
diluted in block solution. Sections were then washed in PBS and incubated for 1 h
at room temperature with Alexa Fluor-conjugated secondary antibodies diluted in
block solution. For both whole mount and frozen section samples, DAPI
counterstain was added during secondary antibody incubations. Samples were then
washed and mounted in VectaShield mounting medium (Vector Labs) and
coverslipped. For human testis sections, standard parafﬁn histology processing
with heat-mediated antigen retrieval was performed prior to
immunoﬂuorescence79. TO-PRO-3 Iodide (Thermo Fisher Scientiﬁc) was used as a
DNA counterstain. All immunoﬂuorescence analyses were performed using a Zeiss
LSM780 confocal microscope (Carl Zeiss) at the Monash Micro Imaging facility.
All image processing and analyses were performed using ImageJ. Primary
antibodies were are follows: goat anti-DDX5 (1:250, Abcam, #ab10261); rabbit anti-
DDX5 (1:500, Abcam, #ab21696); goat anti-GFRα1 (1:250, R&D Systems, #AF560);
rat anti-GILZ (1:1000, eBioscience, #14-4033-82); goat anti-PLZF (1:500, R&D
Systems, #AF2944); goat anti-c-KIT (1:250, R&D Systems, #AF1356); rabbit anti-
ILF3 (1:500, Abcam, #ab92355); goat anti-SOX3 (1:250, R&D Systems, #AF2569);
rabbit anti-VASA (1:250, Cell Signalling Technology, #8761); rabbit anti-SOX9
(1:1000, Millipore, #AB5535); rabbit anti-SCP3 (1:500, Abcam, #ab15093). All
Alexa Fluor secondary antibodies against appropriate species were raised in donkey
and used at 1:500 dilution (Thermo Fisher Scientiﬁc).
Cell culture and immunoﬂuorescence. Murine undifferentiated spermatogonia
cultures were established from 6-week-old mice following enzymatic digestion of
whole testis extracts with collagenase and trypsin12. Undifferentiated spermato-
gonia were cultured on mitomycin-inactivated mouse embryonic ﬁbroblast (MEF)
feeder cells and maintained in StemPro-34 medium (Thermo Fisher Scientiﬁc)
supplemented with 10 ng/ml GDNF, 10 ng/ml bFGF, 20 ng/ml EGF, 25 μg/ml
insulin plus other additives13. For culture of Ddx5ﬂox/ﬂox; UBC-CreERT2 MEFs,
embryos were collected at E13.5 and MEFs isolated according to a standard pro-
tocol80. MEFs were maintained in DMEM (Thermo Fisher Scientiﬁc) supple-
mented with 10% v/v FBS, 1X non-essential amino acids (Thermo Fisher
Scientiﬁc), 1× L-glutamine (Thermo Fisher Scientiﬁc) and 1× Penicillin/Strepto-
mycin (Thermo Fisher Scientiﬁc). For gene knockout experiments, cells were
treated with medium supplemented with 0.2 μM 4-hydroxytamoxifen (4-OHT)
(Sigma-Aldrich) for four consecutive days. Following treatment, 4-OHT-
supplemented medium was replaced with standard culture medium until the
required collection time point. For subsequent analyses, cells were collected by
dissociation with 0.5% v/v trypsin-EDTA (Thermo Fisher Scientiﬁc).
Immunoﬂuorescence on cultured cells was performed using LabTek chamber
slides coated with Geltrex Matrix (Thermo Fisher Scientiﬁc)12. Antibodies used are
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described above (see Whole mount and frozen section immunoﬂuorescence), as
well as: rabbit anti-cleaved CASP3 (1:500, Cell Signalling Technology, #9579);
rabbit anti-SALL4 (1:2000, Abcam, #ab29112); chicken anti-GFP (1:5000, Abcam,
#ab13970); rabbit anti-mCherry (1:2000, Abcam, #ab1647453); rabbit anti-DDX17
(1:250, Bethyl Laboratories, #A300-509A); and rabbit anti-RAD50 (1:250, Abcam,
#ab124682).
Apoptosis inhibitor experiments. Undifferentiated spermatogonia were cultured
and treated with 0.2 μM 4-OHT as described above (see Cell culture and immu-
noﬂuorescence). To inhibit apoptosis, Z-VAD(OMe)-FMK (Z-VAD-FMK) (Cell
Signalling Technology) reconstituted in DMSO was added at a ﬁnal concentration
of 50 μM in conjunction with 4-OHT treatment. An equivalent amount of DMSO
was used as a vehicle control. Following 4-OHT treatment, medium was replaced
with standard culture medium supplemented with 50 μM Z-VAD-FMK until
collection for further analyses or ﬁxation for immunoﬂuorescence.
Co-immunoprecipitation and western blot. Cultured wildtype murine undiffer-
entiated spermatogonia were used for all co-immunoprecipitation experiments.
Co-immunoprecipitation was performed using protein G sepharose beads (GE
Healthcare) according to manufacturer’s instructions and western blots performed
according to standard western blotting protocols13,14. Antibodies used for immu-
noprecipitation were as follows: Armenian hamster anti-PLZF (clone 13G10)13 and
goat anti-DDX5 (Abcam, #ab10261). Ten micrograms of antibody was used for
each experiment. For western blots, antibodies used were as follows: Armenian
hamster anti-PLZF (clone 9E12, 1:2000);14 rabbit anti-DDX5 (1:2000, Cell Sig-
nalling Technology, #98775); rabbit anti-ILF3 (1:10000, Abcam, #ab92355); rabbit
anti-ELAVL1 (1:1000, Abcam, #ab200342); rabbit anti-PABP1 (1:1000, Cell Sig-
nalling Technology, #4992); mouse anti-SRSF3 (1:2000, Sigma-Aldrich, clone 2D2);
rabbit anti-ILF2 (1:1000, Abcam, #ab154791); rabbit anti-IMP3 (1:1000, Abcam,
#ab177477); and rabbit anti-TFEB (1:1000, Bethyl Laboratories. #A303-673A).
Horseradish peroxidase conjugated secondary antibodies were used (GE Healthcare
and Jackson ImmunoResearch) in combination with Pierce ECL western blotting
substrate (Thermo Fisher Scientiﬁc) for detection.
Mass spectrometry and gene ontology analysis. Lysates from cultured undif-
ferentiated spermatogonia were prepared using lysis buffer containing 50 mM Tris-
HCl pH 8.0, 150 mM NaCl, 5 mM EDTA pH 8.0, 0.5% v/v Nonidet P-40 (Sigma-
Aldrich), 1 mM dithiothreitol (Sigma-Aldrich), and protease inhibitor cocktail
(Roche)76. DDX5 and PLZF complexes were immunoprecipitated with goat anti-
DDX5 antibody (Abcam, #ab10261) and goat anti-PLZF antibody (R&D Systems,
#AF2944), respectively, coupled with Dynabeads using a Dynabead Coupling Kit
(Thermo Fisher Scientiﬁc) according to manufacturer’s instructions. Elution and
preparation of samples for mass spectrometry analysis was performed as described
previously at the Bio21 Proteomics Facility12. Gene ontology analysis was per-
formed on mass spectrometry data with PANTHER43 v13.0 using PANTHER
Overrepresentation Test (Fisher’s Exact with FDR multiple test correction, FDR
<0.05) and complete GO annotations for molecular function and biological
process.
Fluorescence-activated cell sorting. Fluorescence-activated cell sorting (FACS)
puriﬁcation was performed on cultured cells to remove contaminating feeder cells
prior to RNA extraction or subsequent analyses or western blot. Following culture
and collection as described above, samples were washed in 2% v/v FBS in PBS and
stained with phycoerythrin (PE)-conjugated EpCAM (1:300, eBioscience, clone
G8.8) for 30 min at 4 °C prior to washing and resuspension in 2% v/v FBS in PBS.
DAPI was added to ﬁnal cell suspensions for live/dead cell discrimination. Sper-
matogonia were puriﬁed according to their expression of EpCAM10. For cultured
cells expressing constructs tagged with GFP or tdTomato, spermatogonia were
isolated based on endogenous ﬂuorescence of these tags, without staining for
EpCAM. Isolation of spermatogonia from testes of control and Plzf –/– mice was
performed following staining with allophycocyanin (APC)-conjugated anti-cKIT
(Biolegend, clone 2B8, #105812), PE-conjugated anti-CD49f (Biolegend, clone
GoH3, #313612), PE-Cyanin7-conjugated anti-EpCAM (Biolegend, clone G8.8,
#118216) and ﬂuorescein isothiocyanate (FITC)-conjugated anti-CD9 (eBioscience,
clone KMC8, #11-0091-82)12. FACS was performed at Monash University Flow-
Core using a BD Inﬂux Cell Sorter (BD Biosciences).
RNA extraction and RT-qPCR. RNA was isolated using TRIzol reagent (Thermo
Fisher Scientiﬁc) and puriﬁed using a Direct-zol MiniPrep kit (Zymo Research)
according to the manufacturer’s instructions, including treatment with DNase I.
cDNA was synthesised using Tetro cDNA synthesis kit (Bioline). qPCR was per-
formed using SYBR Premix Ex Taq II (Takara) and run on a Light Cycler 480
(Roche) or Mic qPCR Cycler (Bio Molecular Systems). Primer sequences used were
obtained from the Harvard PCR Primer Bank (http://pga.mgh.harvard.edu/
primerbank/) and are included in Supplementary Table 1. Differences between
conditions were calculated using the ΔΔCt method.
RNA-sequencing and analysis. RNA was isolated from FACS-puriﬁed cultured
spermatogonia as described above. RNA quality was evaluated using Bioanalyzer
and RNA quantity was determined using Qubit. Samples were prepared starting
with 1 μg of total RNA and libraries generated according to the Illumina Stranded
mRNA protocol using 12 cycles of ampliﬁcation. Library size (~350 bp) was
checked using Bioanalyzer and quantiﬁed with Qubit and qPCR. Based on qPCR
results, a single equimolar pool was prepared and denatured with a ﬁnal
mRNA stabilitySplicing
Transcription
Subsets of essential
pre-mRNA transcripts
Association with other RBPs
to regulate mRNA stability
Export of cyclin mRNAs
e.g. Ccnd1, Ccnd2
Co-operation with other RBPs
for mRNA export
Maintenance of
cycliln mRNA stability
e.g. Ccnb2Spermatogenesis: Dazl, Ehmt2
DNA repair: Rad50, Rad18
autophagy: Becn1
DDX5
DDX5
PLZF
CACGTG
E-box
PABP1ELAVL1
IIf3
ILF3
ILF3
DDX5 DDX5
DDX5
DDX5
mRNA export
Fig. 8 Model of DDX5-mediated gene regulation in undifferentiated spermatogonia. DDX5 plays an essential role in the post-transcriptional regulation of
gene expression within undifferentiated spermatogonia. DDX5 is required for the appropriate splicing of key genes involved in spermatogenesis, DNA
repair and autophagy, and is important for cell cycle regulation through maintenance of cyclin mRNA transcript stability and nuclear export. Post-
transcriptional regulation by DDX5 is likely mediated through interactions with other RNA-binding proteins in a context-dependent manner. DDX5 also
plays a transcriptional role, interacting with PLZF (and other potential binding partners such as E-box binding proteins) to co-regulate transcription of Ilf3,
thereby maintaining cell cycle progression through downstream effects on cyclin mRNA transcripts
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concentration of 200 pM of library pool clustered in one lane of an Illumina HiSeq
3000 (100 bp paired-end) 8-lane ﬂow cell using c-Bot. RNA-sequencing was per-
formed at the Medical Genomics Facility, Monash Health Translation Precinct
(MHTP). Raw sequencing reads in FASTQ format were ﬁltered and trimmed with
Trimmomatic81 (v0.36, Phred score of 6 consecutive bases below 15, minimum
read length of 36 nt), mapped to the complete mouse genome (GENCODE
GRCm38 primary, annotation version vM15) with STAR82 (v2.4.2a) followed by
gene read counting with featureCounts83 (v1.5.2, reverse stranded). Only genes
with more than 5 sequencing reads and 2 counts per million of mapped reads in at
least 4 library-sized normalised samples were considered for further analysis.
Differential gene expression was performed with Degust webtool (http://degust.erc.
monash.edu/) using limma-voom84,85. Genes with a false discovery rate (FDR)
<0.05 were considered to be differentially expressed. Pathway analysis was per-
formed with Ingenuity Pathway Analysis (IPA) (QIAGEN Inc., https://www.
qiagenbioinformatics.com/products/ingenuity-pathway-analysis) using all differ-
entially expressed genes (FDR <0.05).
Differential splicing analysis was performed using the MISO v0.5.4 probabilistic
framework45 (in the conﬁguration where ﬁlter_results= TRUE) and the mm10
alternative event annotation (v2.0). For each alternative splicing event type, pooled
treatment replicates were compared with combined control replicates using
miso_compare and results ﬁltered using ﬁlter_events (num-inc 1, num-exc 1, num-
sum-inc-exc 10, delta-psi 0.20, bayes-factor 10).
PCR validation of differential splicing analysis. RNA was extracted from
vehicle-treated and TAM-treated Ddx5TAM-KO cultured undifferentiated sperma-
togonia and cDNA synthesised as described above (see Cell culture and immu-
noﬂuorescence and Apoptosis inhibitor experiments). Primers for validation of
differentially spliced exons detected by MISO were designed using Primer3 (http://
primer3.ut.ee). Primers were designed within constitutive exons ﬂanking the exon
of interest. Standard PCR for analysis by gel electrophoresis was performed using
JumpStart REDTaq ReadyMix Reaction Mix (Sigma-Aldrich) according to the
manufacturers’ instructions and visualised by running on a 2% agarose gel. Primer
sequences used are found in Supplementary Table 1. Uncropped gels are presented
in Supplementary Fig. 12.
Nuclear-cytoplasmic fractionation. Vehicle-treated and TAM-treated Ddx5TAM-
KO cultured undifferentiated spermatogonia were treated with Z-VAD-FMK as
described above (see Cell culture and immunoﬂuorescence and Apoptosis inhibitor
experiments). Following dissociation with trypsin, cells were feeder depleted
according to differential adhesion to cell culture dishes. For nuclear-cytoplasmic
fractionation and RNA extraction, dissociated spermatogonia were pelleted by
centrifugation and resuspended in PBS once to wash, then centrifuged again and
supernatant removed. Cells were lysed by resuspension in hypotonic lysis buffer
containing 10 mM HEPES pH 7.4 (Thermo Fisher Scientiﬁc), 10 mM NaCl, 3 mM
MgCl2 and 0.313% IGEPAL CA-630 (Sigma-Aldrich) in DNase/RNase-free deio-
nised water. Samples were incubated for 5 min on ice and centrifuged for 8 min at
2000 × g at 4 °C. The supernatant containing the cytoplasmic fraction was collected
and the nuclear pellet was washed once in hypotonic lysis buffer before centrifu-
ging again for 5 min at 2000 × g at 4 °C. The supernatant was removed and
resulting nuclear pellet and previously collected cytoplasmic fraction were pro-
cessed for RNA extraction as described above (see RNA extraction and RT-qPCR).
Nuclear-cytoplasmic ratios were calculated using the ΔΔCt method.
mRNA stability assays. Vehicle-treated and TAM-treated Ddx5TAM-KO cultured
undifferentiated spermatogonia were treated with Z-VAD-FMK as described above
(see Cell culture and immunoﬂuorescence and Apoptosis inhibitor experiments).
For mRNA stability assays, cells were treated with 10 μM actinomycin-D (Sigma-
Aldrich) for up to four hours, with cell samples collected at 0, 2, and 4 h post-
treatment. At each time point and following dissociation with trypsin, cells were
feeder depleted according to differential adhesion to cell culture dishes prior to
RNA extraction, cDNA synthesis and RT-qPCR analysis as described above (see
RNA extraction and RT-qPCR).
Western blotting. For western blots, cells were lysed (following FACS puriﬁcation
for spermatogonia) and processed according to standard western blotting proto-
cols14. For western blot analysis of Ddx5TAM-KO cultured spermatogonia, cells
(including control samples) were treated with Z-VAD-FMK as described above in
order to obtain enough material for protein analysis (see Apoptosis inhibitor
experiments). Antibodies used were as described above (see Co-
immunoprecipitation and western blots), as well as: rabbit anti-DDX17 (1:1000,
Bethyl Laboratories, #A300-509A); rabbit anti-CCND1 (1:1000, Novus Biologicals,
#NB600-584); rabbit anti-CCND2 (1:1000, Santa Cruz Biotechnology, sc-593);
mouse anti-Cyclin A (1:500, Sigma-Aldrich, #C4710); mouse anti-β-actin (1:2000,
Sigma-Aldrich, #A2228); rabbit anti-RAD50 (1:1000, Abcam, #ab124682); and
rabbit anti-ILF3 (1:10000, Abcam, #ab92355). Uncropped blots are presented in
Supplementary Fig. 12.
Cell cycle analysis and ﬂow cytometry. Analysis of cell cycling by ﬂow cytometry
was performed using Click-iT Plus EdU Paciﬁc Blue Flow Cytometry kit (Thermo
Fisher Scientiﬁc) according to manufacturer’s instructions12. EdU incorporation
was performed under standard cell culture conditions for 3 h. Cell ﬁxation with 4%
PFA and methanol permeabilisation was performed as described previously12,17.
Intracellular staining was performed with Alexa 647-conjugated anti-PLZF anti-
body13. Preparation of whole testis extracts to isolate cells for ﬂow cytometry
analyses was performed as described previously12,13,17. Cells were stained with
Alexa 647-conjugated anti-PLZF antibody13, PE-conjugated anti-CD117 (c-KIT)
antibody (1:250, eBioscience, clone 2B8, #12-1171-82) and goat anti-DDX5 (1:250,
Abcam, #ab10261) with donkey anti-goat Alexa Fluor 488 (1:500, Thermo Fisher
Scientiﬁc, #A-11055). Cells were analysed at Monash University FlowCore using an
LSR Fortessa Flow Cytometer (BD Biosciences) and data processed with FlowJo
software.
Cloning of Ddx5 constructs and lentiviral transduction. DDX5 wildtype and
DDX5 helicase mutant constructs were generated and described in a previous study
by Bates et al.42. DDX5 constructs were subcloned into a PCCL-hPGK vector86
modiﬁed to express a tdTomato ﬂuorescent protein tag. First, the P2A-tdTomato
sequence from pCDH1-EF1-Luc2-P2A-tdTomato vector (a gift from Kazuhiro
Oka, Addgene plasmid #72486) was ampliﬁed by PCR using complimentary pri-
mers that included a BglII, BamHI and SalI recognition site at the 5′ end and XhoI
recognition site at the 3′ end (F: 5′-GAA GAT CTG GAT CCG TCG ACG GAA
GCG GAG CTA CTA A-3′; R: 5′-CGC CGC TCG AGT TAT TAC TTG TAC
AGC TCG TC-3′). The PCR product was cloned by BglII/XhoI restriction diges-
tion and ligation into BamHI/SalI sites of the PCCL-hPGK vector. As a result,
original BamHI and SalI sites present in the PCCL-hPGK vector were destroyed
and new BamHI and SalI sites created preceding P2A-tdTomato (new vector
referred to as PCCL-hPGK-P2A-tdTomato). DDX5 constructs were then ampliﬁed
by PCR using complimentary primers that included a BglII recognition site at the
5’ end and SalI site at the 3′ end (F: 5′-GGA AGA TCT GCC ATG GAA CAA
AAA CTC ATC TCA G-3′; R: 5′-GCC GAC GTC GAC TTG GGA ATA TCC TGT
TGG C-3′). The resulting PCR product was cloned by BglII/SalI restriction digest
and ligation into the BamHI/SalI sites of PCCL-hPGK-P2A-tdTomato vector. All
PCR, digestion and ligation reactions were performed using appropriate com-
mercially available kits (New England Biolabs). PCR product puriﬁcation was
performed using PureLink PCR Puriﬁcation kit (Thermo Fisher Scientiﬁc). All
plasmid transformations were performed using One Shot TOP10 chemically
competent E. coli according to manufacturer’s instructions (Thermo Fisher Sci-
entiﬁc) and colonies were selected based on ampicillin resistance. All DNA pur-
iﬁcation was performed using PureLink HiPure Plasmid Midiprep kits (Thermo
Fisher Scientiﬁc). Sanger sequencing was performed to conﬁrm successful cloning
of each construct. For lentivirus production, HEK293T cells were transfected with
cloned DDX5 constructs (10 µg) and packaging plasmids pMDL (5 µg), pRSV-rev
(2.5 µg) and pVSV-G (3 µg) using Lipofectamine-2000 (Thermo Fisher Scientiﬁc).
Lentiviral-containing supernatant was collected in spermatogonia culture medium
48 and 72 h after transfection. Undifferentiated spermatogonia cultures were
infected with lentiviral-containing supernatant supplemented with 8 μg/ml poly-
brene (Millipore). Successfully infected cells were selected by FACS according to
expression of tdTomato (see Fluorescence-activated cell sorting puriﬁcation) and
re-plated for subsequent analyses. Cells infected with PCCL-hPGK-tdTomato were
used for control experiments.
ChIP-sequencing and motif analysis. Chromatin immunoprecipitation was per-
formed using digested chromatin from two independently derived lines of cultured
wildtype undifferentiated spermatogonia prepared with SimpleChIP Enzymatic
Chromatin IP Kit (Cell Signalling Technology #9003)12,14. The antibody used for
immunoprecipitation was: goat anti-DDX5 (Abcam ab10261 Lot# GR183991-1).
Samples were quantiﬁed by Qubit and 20 ng of DNA was used as starting amounts
for all libraries. Samples were sheared by Covaris to ~200–300 bp prior to library
generation. Libraries were constructed using Ovation Ultralow System V2 using
Nugen protocol M01379v1, 2014. Libraries were initially quantiﬁed by Qubit and
size proﬁle determined using Bioanalyzer followed by quantiﬁcation by qPCR and
pooled in equimolar ratio. Upon qPCR, 200 pM of a library pool was used for
cluster generation with c-bot (Ilumina Protocol 15006165 v02 Jan 2016). Two lanes
of Illumina HiSeq3000 (Ilumina Protocol 15066493 Rev A, February 2015) were
used for 50 bp single end reads. ChIP-sequencing was performed at the Medical
Genomics Facility, Monash Health Translation Precinct (MHTP) and data was
processed by the Monash University Bioinformatics Platform. Raw reads from the
ChIP-seq libraries were mapped to the UCSC mouse genome (mm10) using the
bowtie2 tool. Good alignment rates were obtained across all libraries with over 97%
mapped reads. Unmapped and low mapping quality reads were ﬁltered out using
samtools. ChIP-seq analysis was performed using the HOMER tool (http://homer.
ucsd.edu/homer/). The ﬁrst step of the HOMER ChIP-seq analysis creates a tag
directory for each ChIP-seq library that generates quality control matrices and
bedGraph ﬁles. Peak identiﬁcation was performed with HOMER’s ﬁndPeaks
function using histone parameters. Peak annotation of individual samples and
peaks common between 2 samples was performed with HOMER annotatePeaks.pl.
Peak annotation determines the distance to the nearest Transcription Start Site
(TSS) and assigns the peak to that gene followed by genomic annotation of the
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region occupied by the centre of the peak. The list of peaks and associated genes are
listed in Supplementary Data 8. Data is deposited in the GEO repository
(GSE110347). Motif analysis was performed on ChIP-seq data using the RSAT
peak-motifs tool (https://rsat01.biologie.ens.fr/rsat/peak-motifs_form.cgi).
Plzf knockdown and ChIP-qPCR. Enzymatically dissociated wildtype undiffer-
entiated spermatogonia were seeded on to a mitotically-inactivated MEF feeder
layer at 1 × 106 cells per well in a 6-well tissue culture plate with 2 ml ﬁnal volume
of culture medium (see Cell culture and immunoﬂuorescence). siRNA knockdown
was performed immediately following passage using ON-TARGETplus Mouse
Zbtb16 siRNA SMARTpool (Horizon Dharmacon, #L-040219-01-0005) or control
ON-TARGETplus Non-targeting Pool (Horizon Dharmacon, #D-001810-10-05).
For transfection (per well), 150 μl Opti-MEM Reduced Serum Media (Thermo
Fisher Scientiﬁc) was combined with 9 μl Lipofectamine RNAiMAX Reagent
(Thermo Fisher Scientiﬁc) in one tube and 150 μl Opti-MEM Reduced Serum
Media (Thermo Fisher Scientiﬁc) was combined with 60 pmol siRNA in a separate
tube. Tubes were combined and incubated for 5 min at room temperature to form
siRNA-lipid transfection complexes. After 5 min, 300 μl transfection complex
mixture was added to each well. Cells were incubated for 18 h at 37 °C, 5% CO2
then culture medium was replaced. Cells were incubated for an additional 24 h
before collection for ChIP experiments. 4 × 106 cells were used for each ChIP.
Knockdown efﬁciency was conﬁrmed by western blot. Chromatin immunopreci-
pitation was performed using digested chromatin prepared using SimpleChIP
Enzymatic Chromatin IP Kit (Cell Signalling Technology #9003)12,14. The antibody
used for immunoprecipitation was: goat anti-DDX5 (Abcam ab10261 Lot#
GR183991-1). Puriﬁed eluted DNA was used for subsequent qPCR analysis using
primers designed within peak regions identiﬁed by HOMER as described above
(see ChIP-sequencing and motif analysis), and control primers designed within
intergenic regions upto 2 kb upstream of identiﬁed peaks. Primers were designed
using Primer3 and are listed in Supplementary Table 2.
RNA immunoprecipitation. Cultured wildtype murine undifferentiated sperma-
togonia were used for all RNA immunoprecipitation (RNA-IP) experiments. Cells
were cultured and collected as described above (see Cell culture and immuno-
ﬂuorescence). RNA immunoprecipitation was performed using an Imprint RNA
Immunoprecipitation Kit (Sigma-Aldrich) according to the manufacturer’s
insructions. Five micrograms of antibody or rabbit IgG was used for immuno-
precipitation. Antibodies used were: rabbit anti-DDX5 (Abcam, #ab21696) and
rabbit anti-ILF3 (Abcam, #ab92355). RNA extraction was performed following
RNA-IP using TRIZol (Thermo Fisher Scientiﬁc) and puriﬁed with Direct-zol
Miniprep Kit (Zymo Research). cDNA synthesis was performed on total extracted
RNA using Tetro cDNA Synthesis Kit (Bioline). qPCR was performed using SYBR
Premix Ex Taq II (Takara) and run on a Mic qPCR Cycler (Bio Molecular Sys-
tems). Using cycle threshold values, fold enrichment versus IgG only pull-down
was calculated for candidate genes. Standard PCR for analysis by gel electro-
phoresis was performed as described above (see PCR validation of differential
splicing analysis). Primer sequences used are found in Supplementary Table 1.
Uncropped gels are presented in Supplementary Fig. 12.
Generation of inducible Ilf3−/− spermatogonia by CRISPR/Cas9. CRISPR/
Cas9 targeting mouse Ilf3 was performed using the inducible lentiviral system
described by Aubrey et al.63. sgRNAs to mouse Ilf3 were designed by CCTop
software (https://crispr.cos.uni-heidelberg.de/). One sgRNA (5′-
TCCCGTTACTGCCGTCTACCTCCA-3′) targeting an exonic sequence common
to all known transcript variants of Ilf3 was selected. Oligonucleotides containing
this sgRNA sequence were synthesised (Integrated DNA Technologies) including a
5’ “TCCC” 4 bp overhang for the complementary sequence and a ′5 “AAAC” 4 bp
overhang for the reverse complementary sequence. Annealed oligonucleotides were
cloned into BsmBI restriction site of the lentiviral vector for doxycycline (DOX)-
inducible sgRNA expression (FgH1tUTG–eGFP expression) provided by Dr.
Marco Herold. Sanger sequencing was performed to ensure sgRNA sequence was
ligated into FgH1tUTG. Lentiviral production and transduction of cells were
performed as described above. Cultured wildtype spermatogonia were initially
infected with FUCas9mCherry and subsequently infected with the sgRNA con-
struct. Cells were then sorted with BD Inﬂux Cell Sorter (BD Biosciences) for
mCherry (Cas9) and eGFP (sgRNA). Expression of sgRNA was induced by
treatment with 2 μg/ml of doxycycline hyclate (Sigma-Aldrich D9891). Knockout
of Ilf3 in spermatogonia was conﬁrmed by immunoﬂuorescence and qRT-PCR.
Statistical analyses. Assessment of statistical signiﬁcance was performed using
two-tailed unpaired t-tests, one-way ANOVA with Tukey multiple comparisons
test or two-way ANOVA with Bonferroni multiple comparisons test for normally
distributed data and two-tailed Mann-Whitney U tests or Kruskal–Wallis with
Dunn’s multiple comparisons tests for data that were not normally distributed.
P-values less than 0.05 were considered statistically signiﬁcant. All statistical ana-
lyses including normality tests were performed using GraphPad Prism v7. For
mouse experiments, no statistical method was used to predetermine sample sizes
and no speciﬁc randomisation or blinding methods were used.
Data availability
PLZF and DDX5 mass spectrometry data have been deposited in the MassIVE repository
under accession code MSV000083476 [https://doi.org/10.25345/C57P6V]. DDX5 RNA-
seq data has been deposited in the Gene Expression Omnibus (GEO) database under
accession code GSE127275 and DDX5 ChIP-seq data has been deposited in GEO under
accession code GSE110347. All data are available within the article or Supplementary
Information or from corresponding author upon reasonable request.
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